From: Ascending aortic wall degeneration in patients with bicuspid versus tricuspid aortic valve
All patients | BAV | TAV | P value | |
---|---|---|---|---|
Number of patients | 67 | 33 | 34 | |
Age (years, interquartile) | 66 (56–71) | 64 (55–72) | 68 (61–71) | 0.133 |
Male, n | 50 (75%) | 26 | 24 | 0.576 |
Hypertension, n | 44 (68%) | 15 | 29 | 0.001 |
Diabetes, n | 9 (14%) | 3 | 6 | 0.475 |
Hypercholesterolemia, n | 17 (26%) | 11 | 6 | 0.166 |
Vasculitis, n | 6 (8%) | 1 | 5 | 0.198 |
Arthritis | 6 (9%) | 2 | 4 | 0.673 |
Asthma, n | 4 (6%) | 0 | 4 | 0.114 |
Myocardial coronary artery disease, n | 14 (21%) | 7 | 7 | 1 |
History of stroke | 4 (6%) | 2 | 2 | 1 |
Earlier abdominal aorta aneurysm surgery | 2 (3%) | 0 | 2 | 0.492 |
Mid-ascending aorta diameter (mm, interquartile) | 54 (50–60) | 53 (50–57) | 55 (52–60) | 0.042 |
Moderate to severe aortic valve regurgitation, n | 36 (56%) | 14 | 22 | 0.139 |